LoginRegister
    Aleor Derma Karakhadi unit clears USFDA inspectionAleor Derma Karakhadi unit clears USFDA inspection
    Strides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MDStrides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MD
    Streamline tax and duty structure in Union Budget 2020-21 to ensure quality medical devices: MTaIStreamline tax and duty structure in Union Budget 2020-21 to ensure quality medical devices: MTaI
    Novartis acquires The Medicines Company, adds cholesterol-lowering therapy inclisiranNovartis acquires The Medicines Company, adds cholesterol-lowering therapy inclisiran
    Esteve to buy German pharma firm Riemser from ArdianEsteve to buy German pharma firm Riemser from Ardian
    Arena Pharma CEO Targets Brain Diseases as Next Drug Frontier- Bloomberg ReportArena Pharma CEO Targets Brain Diseases as Next Drug Frontier- Bloomberg Report
    Daiichi Sankyo introduces Enhertu - breast cancer drug in USDaiichi Sankyo introduces Enhertu - breast cancer drug in US
    Keytruda plus chemotherapy results in statistically significant improvement in PFS compared to chemotherapy aloneKeytruda plus chemotherapy results in statistically significant improvement in PFS compared to...
    Slayback Pharma raises USD 50 million in Series B funding from Everstone GroupSlayback Pharma raises USD 50 million in Series B funding from Everstone Group
    DCGI to conduct Special Public Hearing every month; DetailsDCGI to conduct Special Public Hearing every month; Details
    Glenmark gets USFDA nod for Deferasirox tablets to treat high levels of ironGlenmark gets USFDA nod for Deferasirox tablets to treat high levels of iron
    AstraZeneca Lokelma gets Chinese approval for treating hyperkalaemiaAstraZeneca Lokelma gets Chinese approval for treating hyperkalaemia
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X